# EMEND

NDC: 0006-3066
Generic name: aprepitant
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: POWDER, FOR SUSPENSION
Routes: ORAL
Marketing started: 20151217

FDA application: NDA207865

## Active ingredients

- APREPITANT: 125 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-3066"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-3066
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=696f9e80-9cae-403b-de9e-078343ce4713